uploads/2016/06/Part-5-Graph-06-07-16-1.png

How Are XLV’s Holdings’ Moving Averages Trending?

By

Updated

XLV’s moving averages

The Health Care Select Sector SPDR ETF (XLV) has 56 stocks in its portfolio. As of June 7, 2016, 84% of XLV’s stocks were trading above their 20-day moving averages, 75% were trading above their 50-day moving averages, and 73% were trading above their 100-day moving averages.

This was a drastic jump compared to the stocks’ moving averages on May 31, 2016. That day, 18% were trading above their 20-day moving averages, 25% were trading above their 50-day moving averages, and 26% were trading above their 100-day moving averages.

The above graph shows the percentage of XLV’s holdings that were trading at various moving averages on June 7, 2016. Of XLV’s 56 stocks, 47 were trading above their 20-day moving averages, 42 were trading above their 50-day moving averages, and 41 were trading above their 100-day moving averages.

Article continues below advertisement

What’s XLV’s moving average trend?

On June 7, XLV closed at $72.23 and was trading above its 20-day, 50-day, and 100-day moving averages. XLV’s 20-day moving average was $70.60. On May 31, 2016, its 20-day moving average was $69.90, indicating an upward trend.

A few XLV stocks are trading above their 20-day and 100-day moving averages

Mylan (MYL), AbbVie (ABBV), Celgene (CELG), and Pfizer (PFE) are a few of XLV’s 47 stocks that are trading above their 20-day moving averages. Let’s take a look at these stocks’ 100-day moving averages.

XLV stocks trading above their 20-day moving averages:

  • Mylan: $41.4 as of May 31, 2016, $42.4 as of June 7, 2016
  • AbbVie: $61.70 as of May 31, 2016, $62.00 as of June 7, 2016
  • Celgene: $102.20 as of May 31, 2016, $103.70 as of June 7, 2016
  • Pfizer: $33.70 as of May 31, 2016, $34.00 as of June 7, 2016

All four stocks showed upward trends.

XLV stocks trading above their 100-day moving averages:

  • Mylan: $46.30 as of May 31, 2016, $46.10 as of June 7, 2016
  • Abbvie: $57.80 as of May 31, 2016, $58.30 as of June 7, 2016
  • Celgene: $103.10 as of May 31, 2016, $103.20 as of June 7, 2016
  • Pfizer: $31.30 as of May 31, 2016, $31.50 as of June 7, 2016

Except Mylan, all the above-mentioned stocks have shown upward trends.

Moving averages help investors to identify price trends and compare stocks’ current prices with their various moving average prices. This can help investors to identify support and resistance levels and make informed investment decisions.

Advertisement

More From Market Realist